The emerging literature data from recently published clinical trials on severe COVID-19 patients revealed that high circulating levels of IL-6, IL-1β, IL-8 and TNF-α were associated with poor prognosis and higher mortality rates [32,33,34]. This evidence concerns the gene IL6 and COVID-19.